Drop in Daytime Activity Patterns Precedes Disability Worsening in MS

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on March 10, 2026.

via HealthDay

TUESDAY, March 10, 2026 -- For people with multiple sclerosis (PwMS), within-person reductions in daytime activity patterns precede clinical disability worsening, according to a study published online March 4 in Neurology.

Kathryn C. Fitzgerald, Sc.D., from the Johns Hopkins School of Medicine in Baltimore, and colleagues examined whether accelerometry detects subtle change in disability among PwMS. Data were included for 238 PwMS aged 40 years or older with approximately annual brain magnetic resonance imaging (MRI) who wore GT9X Actigraph accelerometers every three months over three years.

The researchers found that 120 PwMS experienced Expanded Disability Status Scale-plus (EDSS+)-confirmed progression during a mean of 2.9 years. There was an average decline of 43,737 activity counts in total activity (2.0 percent decline per year). A higher risk for EDSS+ was seen in association with within-person decreases in daytime activity (particularly between 8:00 and 14:00). A one-standard deviation decrease in within-person activity from 8:00 to 10:00, 10:00 to 12:00, and 12:00 to 14:00 was associated with a 1.20, 1.24, and 1.23 higher risk for EDSS+-confirmed disability progression, respectively. Within-person declines in morning activity (8:00 to 10:00) were also associated with greater whole-brain, deep gray matter, and thalamic volume loss in MRI models (−0.18, −0.34, and −0.35 percent, respectively). Over time, lower between-person mean moderate-to-vigorous physical activity was associated with lower brain volumes, but no association was seen with EDSS+.

"Timely identification of patients at risk for disease progression is essential to reduce long-term disability," Fitzgerald said in a statement. "Using a relatively inexpensive and accessible device around the wrist may help us identify early changes in the disease."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-11 01:42

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords